Bogdan Fetică

Iuliu Hațieganu University of Medicine and Pharmacy — Romania

Medicine · Health Sciences

15h-index835citations99works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(18), Viral-associated cancers and disorders(9), Breast Cancer Treatment Studies(8), Chronic Lymphocytic Leukemia Research(7), Cancer, Lipids, and Metabolism(6)

Publications99 total

Ultrasound-based comparative assessment of ipsilateral vs. contralateral axillary lymph nodes in breast cancer patients — a pilot study
Frontiers in Oncology·2025Open Access
STUMP Swiftly Followed by Large Adenomyoma in a Young Nulliparous Patient
Diagnostics·2025Open Access
Familial Von Hippel–Lindau Disease: A Case Series of Cerebral Hemangioblastomas with MRI, Histopathological, and Genetic Correlations
Life·2025Open Access
Challenges in the preclinical design and assessment of CAR-T cells
Frontiers in Immunology·2025· 5 citedOpen Access
PTEN and ERG Biomarkers as Predictors of Biochemical Recurrence Risk in Patients Undergoing Radical Prostatectomy
Diseases·2025Open Access
Evaluating the Effectiveness of Neoadjuvant Therapy in Her2-Positive Invasive Breast Cancer: A Comprehensive Analysis of 167 Cases in Romania
Cancers·2025Open Access
The Genomic Landscape of Romanian Non-Small Cell Lung Cancer Patients: The Insights from Routine NGS Testing with the Oncomine™ Dx Express Test at the PATHOS Molecular Pathology Laboratory
Cancers·2025· 1 citedOpen Access
FICTION Technique—A Candidate for the Assessment of HER2 Status in Breast Invasive Carcinomas
Medicina·2025· 1 citedOpen Access
875 | JOINT ANALYSIS OF 1695 CASES OF MALIGNANT LYMPHOMA FROM THE UKRANIAN AND CLUJ NAPOCA LYMPHOMA REGISTRIES
Hematological Oncology·2025Open Access
894 | REAL LIFE EXPERIENCE WITH SILTUXIMAB IN CASTLEMAN DISEASE
Hematological Oncology·2025Open Access
883 | SILTUXIMAB IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: REAL‐WORLD EXPERIENCE FROM ROMANIA AND GREECE
Hematological Oncology·2025Open Access
Tumor-Associated Macrophages as Key Modulators of Disease Progression in Diffuse Large B-Cell Lymphoma
Biomedicines·2025· 1 citedOpen Access
Laparoscopic sealing devices on animal models: searching the least harmful for the surrounding tissue
Medicine and Pharmacy Reports·2024Open Access
Intraoperative imaging of residual ovarian cancer after neoadjuvant chemotherapy using indocyanine green
International Journal of Gynecological Cancer·2024· 2 citedOpen Access
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience
Journal of Hematology·2024· 5 citedOpen Access
The transcriptional landscape of cancer stem-like cell functionality in breast cancer
Journal of Translational Medicine·2024· 6 citedOpen Access
Impact of Immunohistochemical Biomarkers on Predicting the Risk of Biochemical Recurrence for Patients that Underwent Radical Prostatectomy: A Literature Review
Archivos Españoles de Urología·2024· 1 cited
Hereditary Breast Cancer in Romania—Molecular Particularities and Genetic Counseling Challenges in an Eastern European Country
Biomedicines·2023· 10 citedOpen Access
Muir-Torre Syndrome: a Long Way to Diagnosis
Journal of Medical and Radiation Oncology·2023Open Access
Whole-Tumor ADC Texture Analysis Is Able to Predict Breast Cancer Receptor Status
Diagnostics·2023· 6 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Patriciu Achimaș-Cădariu(13), Ciprian Tomuleasa(11), Mihnea Zdrenghea(10), Cătălin Vlad(8), Ovidiu Bălăcescu(8), Ioana Berindan‐Neagoe(8), Delia Dima(8), Bogdan Pop(7), Adrian P. Trifa(7), Loredana Bălăcescu(7), Oana Tudoran(7), Simona Vișan(7), Alexandru Irimie(7), Bobe Petrushev(7), Andrei Roman(7), Laura Pop(6), Sergiu Paşca(6), Carmen Lisencu(6), Anca Bojan(5), Annamaria Fulop(5)